OpenURL Connection Search

Select item for more details and to access through your institution.

Structural Basis for the Inhibition of a Phospholipase A<sub>2</sub>-Like Toxin by Caffeic and Aristolochic Acids.
Published in:
PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0133370
By:
- Fernandes, Carlos A. H.;
- Cardoso, Fábio Florença;
- Cavalcante, Walter G. L.;
- Soares, Andreimar M.;
- Dal-Pai, Maeli;
- Gallacci, Marcia;
- Fontes, Marcos R. M.
Publication type:
Article
Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70064-8
By:
- Ramos da Silva Grillo, Vinicius Tadeu;
- Bertanha, Matheus;
- da Silva Rodrigues, Lenize;
- de Lima, Marcelo Andrade;
- Mellucci Filho, Pedro Luciano;
- Rahal Guaragna Machado, Rafael;
- Durigon, Edson Luiz;
- Dias Sertorio, Nathália;
- de Assis Golim, Marjorie;
- Moroz, Andrei;
- Marques Braz, Aline Márcia;
- de Moraes, Leonardo Nazário;
- Leite, Marco Antonio;
- Bonciani Nader, Helena;
- de Campos, Gustavo Constantino;
- Rodrigues Guzzo Carvalho, Cristiane;
- Florença Cardoso, Fábio;
- Magro, Angelo José;
- Caputo Nunes, Helga;
- Tommasini Grotto, Rejane Maria
Publication type:
Article
Search for efficient inhibitors of myotoxic activity induced by ophidian phospholipase A<sub>2</sub>-like proteins using functional, structural and bioinformatics approaches.
Published in:
Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-36839-6
By:
- Salvador, Guilherme H. M.;
- Cardoso, Fábio Florença;
- Gomes, Antoniel A.;
- Cavalcante, Walter L. G.;
- Gallacci, Márcia;
- Fontes, Marcos R. M.
Publication type:
Article

Found: 3

Structural Basis for the Inhibition of a Phospholipase A<sub>2</sub>-Like Toxin by Caffeic and Aristolochic Acids.

Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial.

Search for efficient inhibitors of myotoxic activity induced by ophidian phospholipase A<sub>2</sub>-like proteins using functional, structural and bioinformatics approaches.